Comparing bowel and urinary domains of patient-reported quality of life at the end of and 3 months post radiotherapy between intensity-modulated radiotherapy and proton beam therapy for clinically localized prostate cancer.
Miao BaiKimberly R GergelisMustafa SirThomas J WhitakerDavid M RoutmanBradley J StishBrian J DavisThomas M PisanskyRichard ChooPublished in: Cancer medicine (2020)
PBT had less acute decrement in BF than IMRT following radiotherapy. There was no difference between the two modalities in UO and UI.